Literature DB >> 8782309

Primary pulmonary lymphoma diagnosed by gene rearrangement: report of a case.

H Miura1, O Taira, O Uchida, N Kajiwara, H Kato.   

Abstract

We report herein the case of a 59-year-old asymptomatic man who was referred to our department for investigation of an abnormal shadow detected on a routine chest roentogenogram. Computed tomography (CT) showed an infiltrative shadow and air bronchogram in the right middle lobe without mediastinal lymphadenopathy, and a right middle lobectomy was performed with hilar and interlobar lymph node excision. Microscopically, the tumor consisted of small lymphoid cells without atypia, admixed with neutrophils and other mononuclear cells, but there was no invasion of the bronchial cartilage or visceral pleura, or any lymph node involvement. Most of the tumor cells were positive for L26 and some for UCHL-1. Although a germinal center was not seen, pseudolymphoma could not be ruled out. Southern blot analysis of the frozen tissues revealed clonal rearrangements of the immunoglobulin heavy-chain JH and light-chain J kappa, whereby the tumor was diagnosed as malignant lymphoma of the small lymphocytic B-cell type. Thus, when such lymphoproliferative diseases which are difficult to diagnose are encountered, frozen tissue should be preserved for genetic analysis.

Entities:  

Mesh:

Year:  1996        PMID: 8782309     DOI: 10.1007/bf00311938

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  16 in total

1.  Low-grade primary B-cell lymphoma of the lung. An immunohistochemical, molecular, and cytogenetic study of a single case.

Authors:  A C Wotherspoon; G N Soosay; T C Diss; P G Isaacson
Journal:  Am J Clin Pathol       Date:  1990-11       Impact factor: 2.493

2.  Pulmonary lymphoma versus pseudolymphoma: a perplexing problem.

Authors:  S D Greenberg; J G Heisler; F Gyorkey; D E Jenkins
Journal:  South Med J       Date:  1972-07       Impact factor: 0.954

3.  Primary lymphoproliferative conditions of lung.

Authors:  A R Gibbs; R M Seal
Journal:  Thorax       Date:  1978-04       Impact factor: 9.139

4.  Primary malignant lymphoma of the lung: histopathologic and immunologic evaluation of nine cases.

Authors:  A Herbert; D H Wright; P G Isaacson; J L Smith
Journal:  Hum Pathol       Date:  1984-05       Impact factor: 3.466

5.  Primary pulmonary lymphoma. A clinical and immunohistochemical study of six cases.

Authors:  H Peterson; H L Snider; L T Yam; C F Bowlds; E H Arnn; C Y Li
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

6.  Pulmonary lymphomas simulating lymphomatoid granulomatosis.

Authors:  T V Colby; C B Carrington
Journal:  Am J Surg Pathol       Date:  1982-01       Impact factor: 6.394

7.  Immunoglobulin-gene rearrangements as unique clonal markers in human lymphoid neoplasms.

Authors:  A Arnold; J Cossman; A Bakhshi; E S Jaffe; T A Waldmann; S J Korsmeyer
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

8.  Pulmonary processes of mature-appearing lymphocytes: pseudolymphoma, well-differentiated lymphocytic lymphoma, and lymphocytic interstitial pneumonitis.

Authors:  P R Julsrud; L R Brown; C Y Li; E C Rosenow; J K Crowe
Journal:  Radiology       Date:  1978-05       Impact factor: 11.105

9.  Primary pulmonary lymphoma: a re-appraisal of its histogenesis and its relationship to pseudolymphoma and lymphoid interstitial pneumonia.

Authors:  B J Addis; E Hyjek; P G Isaacson
Journal:  Histopathology       Date:  1988-07       Impact factor: 5.087

10.  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

Authors: 
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

View more
  1 in total

1.  Duodenal pseudolymphoma: a case report and review of literature.

Authors:  Yong-Heng Huang; Tian-Zhu Long; Zhi-Yu Xiao; Hua Ye; Yun-Le Wan; Jie Wang
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.